← Back to Search

Resistance Training for Pancreatic Cancer

N/A

Waitlist Available

Led By Nathan H Parker

Research Sponsored by M.D. Anderson Cancer Center

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 3-4 months

Awards & highlights

Study Summary

This trial looks at the safety of using a tablet to do resistance training exercises. It may help improve quality of life for patients with pancreatic cancer.

Who is the study for?

This trial is for adults with advanced pancreatic cancer who are undergoing chemotherapy or have had surgery. They must be in good physical condition (ECOG 0-1), able to participate in tele-exercise sessions, and have Wi-Fi at home. Pregnant women, non-English speakers, those already doing regular resistance training, or with certain health issues like severe pain or unstable heart disease cannot join.Check my eligibility

What is being tested?

The study tests a tele-exercise resistance training program using tablets to see if it helps maintain muscle strength, physical function, and life quality for pancreatic cancer patients during chemo or post-surgery. Participants will do exercises remotely while being monitored by the research team.See study design

What are the potential side effects?

Since this intervention involves exercise rather than medication, side effects may include typical exercise-related risks such as muscle soreness or strain. However, participants with conditions that could make exercise unsafe are excluded from the trial.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 3-4 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~3-4 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 3-4 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Aerobic fitness

Body composition

Post-exercise muscle soreness

+1 more

Secondary outcome measures

Acceptability for Feasibility

Acceptability for participants

Acceptability for providers

+12 more

Trial Design

1Treatment groups

Experimental Treatment

Group I: Supportive care (resistance training)Experimental Treatment4 Interventions

SEE DETAILED DESCRIPTION.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

M.D. Anderson Cancer CenterLead Sponsor

2,966 Previous Clinical Trials

1,804,756 Total Patients Enrolled

Nathan H ParkerPrincipal InvestigatorM.D. Anderson Cancer Center

Karen Basen-Engquist, BA,MPH,PHDPrincipal InvestigatorM.D. Anderson Cancer Center

Media Library

Quality-of-Life Assessment Clinical Trial Eligibility Overview. Trial Name: NCT04837118 — N/A

Pancreatic Cancer Research Study Groups: Supportive care (resistance training)

Pancreatic Cancer Clinical Trial 2023: Quality-of-Life Assessment Highlights & Side Effects. Trial Name: NCT04837118 — N/A

Quality-of-Life Assessment 2023 Treatment Timeline for Medical Study. Trial Name: NCT04837118 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What are the goals of this investigation?

"The primary outcome that will be assessed over the course of 3-4 months is body composition. Additionally, Chemotherapy-induced peripheral neuropathy (CIPN) will be self-reported using a 20 point questionnaire and Acceptability for Feasibility, as well as Dynamic upper- and lower-body muscular strength are also being evaluated through 1RM lifts."

Answered by AI

What is the numerical extent of participation in this clinical experiment?

"Affirmative, the details available on clinicaltrials.gov demonstrate that this trial is still recruiting participants. It was first put up for consideration on February 15th 2021 and last modified April 7th 2021. The study necessitates 75 patients from one medical facility to participate."

Answered by AI

Is there any availability for participants in this research project?

"Affirmative. Per the information housed on clinicaltrials.gov, this scientific experiment is actively seeking participants, having been initially posted on February 15th 2021 and most recently updated April 7th 2021. A total of 75 people are needed to enroll from just 1 site."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Resistance Training Intervention to Improve Physical Function in Patients With Pancreatic Cancer Receiving Combination Chemotherapy or Have Undergone Surgery, PancStrength Study

2021. "Resistance Training Intervention to Improve Physical Function in Patients With Pancreatic Cancer Receiving Combination Chemotherapy or Have Undergone Surgery, PancStrength Study". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04837118.